Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has requested a voluntary suspension of its securities from the Australian Securities Exchange (ASX) pending a court application. This action is to ensure that trading does not occur on an uninformed basis while the company seeks to validate a cleansing notice related to share issuance. The suspension will remain until the court’s decision or a further announcement by the company, expected by May 2, 2025.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions aimed at improving medication management and adherence. The company focuses on leveraging technology to enhance patient engagement and streamline pharmacy operations.
YTD Price Performance: -56.36%
Average Trading Volume: 625,297
Technical Sentiment Signal: Buy
Current Market Cap: A$57.38M
Learn more about MDR stock on TipRanks’ Stock Analysis page.